Violaine O.
- Country
- France
- Department
- Hépatologie
Research Overview
- Phase 1b Study of NP137 with Atezolizumab-Bevacizumab in First-Line Treatment of Unresectable Hepatocellular Carcinoma
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa in Adults with Biopsy‑Confirmed F2–F3 Metabolic Dysfunction‑Associated Steatohepatitis
- Phase 3 Randomized Double‑Blind Placebo‑Controlled Study of Efimosfermin Alfa Safety and Tolerability in Adults with F2‑F3 Metabolic Dysfunction‑Associated Steatohepatitis
Data & Insights
Has run more than one trial at 119 of 214 partner sites.
Specializations
Liver Cancer Research
Specializes in therapeutic approaches for hepatocellular carcinoma (HCC), including both early-stage and advanced disease states. Investigates innovative treatment combinations integrating targeted therapies and immunotherapy approaches.
- Early-stage HCC management
- Advanced liver cancer treatments
- Combination therapy strategies
Hepatobiliary Disorders
Focuses on treating complex liver conditions including liver adenomas, cholangiocarcinoma, and non-alcoholic steatohepatitis (NASH). Explores novel therapeutic agents targeting specific molecular pathways.
- Inflammatory liver conditions
- Bile duct cancer treatments
- Metabolic liver disease
Portal Hypertension Management
Conducts research in cirrhosis complications and portal hypertension. Studies therapeutic interventions using both established medications and novel compounds for preventing disease progression.
- Cirrhosis management
- Prevention of decompensation
- Portal pressure reduction strategies
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.